Update on the pharmacological treatment of Alzheimer's disease.
Alzheimer's disease (AD) is the most common neurodegenerative disorder. Worldwide prevalence of the disease is estimated at more than 24 million cases. With aging of populations, this number will likely increase to more than 80 million cases by the year 2040. The annual incidence worldwide is estimated at 4.6 million cases which is the equivalent of one new case every seven seconds! The pathophysiology of AD is complex and largely misunderstood. It is thought to start with the accumulation of beta-amyloid (αβ) that leads to deposition of insoluble neuritic or senile plaques. Secondary events in this "amyloid cascade" include hyperphosphorylation of the protein tau into neurofibrillary tangles, inflammation, oxidation, and excitotoxicity that eventually cause activation of apoptotis, cell death and neurotransmitter deficits. This review will briefly summarize recent advances in the pathophysiology of AD and focus on the pharmacological treatment of the cognitive and functional symptoms of AD. It will discuss the roles of vascular prevention, cholinesterase inhibitors and an NMDA-antagonist in the management of AD. It will address the issues thought to be related to the lack of persistence or discontinuation of therapy with cholinesterase inhibitors shown in recent studies and some of the solutions proposed. These include setting realistic expectations in light of a neurodegenerative condition and available symptomatic treatments, slowly titrating medications, and using alternate routes of administration. Finally, it will introduce future therapeutic options currently under study.
Massoud
Fadi
F
Department of Medicine, University of Montreal, Centre Hospitalier de l'Université de Montréal (CHUM), Hôpital Notre-Dame, Service de Gériatrie, 1560 Sherbrooke Est, Montreal, Quebec, H2L 4M1. fadi.massoud.chum@ssss.gouv.qc.ca
Gauthier
Serge
S
Alzheimer Dis Assoc Disord. 1997;11 Suppl 2:S22-32
9236949
Expert Opin Drug Saf. 2009 Jan;8(1):89-109
19236221
Cochrane Database Syst Rev. 2006 Jan 25;(1):CD001747
16437436
J Neurol Neurosurg Psychiatry. 2004 May;75(5):677-85
15090558
Neurology. 2005 May 10;64(9):1553-62
15883316
J Clin Invest. 2004 May;113(10):1384-7
15146234
J Am Geriatr Soc. 2003 Jul;51(7):937-44
12834513
Int J Geriatr Psychiatry. 2009 May;24(5):479-88
18985627
Am J Hypertens. 1999 Nov;12(11 Pt 1):1130-4
10604491
J Neurosci. 1992 Feb;12(2):376-89
1346802
J Psychiatr Res. 1975 Nov;12(3):189-98
1202204
Lancet Neurol. 2008 Sep;7(9):805-11
18667360
N Engl J Med. 2004 Jul 1;351(1):56-67
15229308
Nat Rev Neurosci. 2003 Feb;4(2):131-8
12563284
Biochem Soc Symp. 2001;(67):81-8
11447842
BMJ. 2005 Aug 6;331(7512):321-7
16081444
Alzheimer Dis Assoc Disord. 2004 Apr-Jun;18 Suppl 1:S24-9
15249845
Trends Pharmacol Sci. 1996 Oct;17(10):348-55
8979769
J Neurol Neurosurg Psychiatry. 2002 Mar;72(3):310-4
11861686
Trends Neurosci. 2002 Jan;25(1):22-6
11801334
Expert Opin Pharmacother. 2007 May;8(7):1011-23
17472546
JAMA. 1997 Mar 12;277(10):813-7
9052711
Acta Neuropathol. 1991;82(4):239-59
1759558
Lancet. 2004 Jun 26;363(9427):2105-15
15220031
Curr Opin Neurobiol. 1995 Oct;5(5):663-8
8580719
Alzheimers Dement. 2007 Oct;3(4):355-84
19595958
Arch Neurol. 1997 Apr;54(4):465-73
9109749
Neurobiol Aging. 2008 Aug;29(8):1204-17
17379359
Alzheimer Dis Assoc Disord. 1997;11 Suppl 2:S33-9
9236950
JAMA. 2004 Jan 21;291(3):317-24
14734594
Neurology. 2009 Sep 1;73(9):674-80
19720973
Exp Neurol. 1995 Feb;131(2):193-202
7895820
Science. 2002 Jul 19;297(5580):353-6
12130773
Neurology. 1994 Dec;44(12):2315-21
7991118
Neurology. 2001 May 8;56(9):1154-66
11342679
J Neuroimaging. 2006 Jan;16(1):16-23
16483272
Science. 1982 Mar 5;215(4537):1237-9
7058341
Neurotox Res. 2003;5(7):491-504
14715433
Clin Ther. 1989 Jul-Aug;11(4):545-54
2776169
Cochrane Database Syst Rev. 2006 Apr 19;(2):CD003154
16625572
Brain. 2009 Sep;132(Pt 9):2356-71
19605530
J Clin Psychopharmacol. 2009 Apr;29(2):147-56
19512976
Curr Neuropharmacol. 2008 Jun;6(2):117-24
19305792
Lancet. 2002 Apr 13;359(9314):1283-90
11965273
Neurology. 2003 Jul 8;61(1):46-54
12847155
Science. 1993 Aug 13;261(5123):921-3
8346443
Neuron. 2003 May 22;38(4):547-54
12765607
Alzheimers Dement. 2007 Oct;3(4):398-403
19595960
J Am Geriatr Soc. 2005 Jul;53(7):1269-70
16108961
J Neuropathol Exp Neurol. 1997 Apr;56(4):321-39
9100663
Neurology. 2007 Dec 11;69(24):2197-204
17568013
Arch Neurol. 2008 Aug;65(8):1031-8
18695053
Arch Neurol. 1994 Jan;51(1):41-5
8274108
Drugs Aging. 2005;22(8):695-707
16060719
Neurobiol Aging. 2000 Mar-Apr;21(2):331-42
10867218
Arch Neurol. 2003 Dec;60(12):1685-91
14676042
J Am Geriatr Soc. 1996 Apr;44(4):411-5
8636587
CMAJ. 1994 Mar 15;150(6):899-913
8131123
Ann Neurol. 2008 Aug;64(2):168-76
18496870
N Engl J Med. 2007 Aug 30;357(9):933-5
17761598
Brain Res Bull. 2010 Jan 15;81(1):3-6
19748552
Brain Pathol. 1991 Apr;1(3):213-6
1669710
J Psychopharmacol. 2006 Nov;20(6):732-55
17060346
Lancet. 2004 Mar 6;363(9411):757-67
15016485
Cochrane Database Syst Rev. 2003;(3):CD001190
12917900
Nat Med. 1996 Aug;2(8):864-70
8705854
J Neurochem. 2006 Nov;99(3):689-707
17076654
Neurology. 2002 Aug 27;59(4):563-72
12196650
J Neural Transm Suppl. 1998;53:169-80
9700655
Neurodegeneration. 1996 Sep;5(3):213-8
8910899
Nat Med. 1996 Oct;2(10):1146-50
8837617
Cochrane Database Syst Rev. 2000;(4):CD001191
11034705
Am J Pathol. 1999 Sep;155(3):853-62
10487842
Clin Interv Aging. 2007;2(1):17-32
18044073
Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9649-53
8415756
Am J Psychiatry. 1984 Nov;141(11):1356-64
6496779
J Neurol Neurosurg Psychiatry. 1999 Feb;66(2):137-47
10071091
Drugs Aging. 2006;23(10):839-42
17067186
BMJ. 2009 Feb 05;338:b75
19196746
Curr Neuropharmacol. 2007;5(2):127-34
18615180
Brain. 2008 Dec;131(Pt 12):3299-310
18953056
Trends Neurosci. 1993 Nov;16(11):460-5
7507619
Nat Med. 2006 Jul;12(7):801-8
16767098
Lancet. 1998 Oct 24;352(9137):1347-51
9802273
Biochem J. 1997 May 1;323 ( Pt 3):577-91
9169588
Drugs Aging. 2009;26(5):403-7
19552492
Lancet. 2002 Nov 23;360(9346):1623-30
12457784
Proc Natl Acad Sci U S A. 2005 Jan 4;102(1):227-31
15615853
Physiol Rev. 2001 Apr;81(2):741-66
11274343
N Engl J Med. 2009 May 28;360(22):2357-9
19474435
Neurology. 2007 Jul 24;69(4 Suppl 1):S14-22
17646619
Lancet Neurol. 2008 Aug;7(8):683-9
18614402
Ann Intern Med. 2004 Apr 20;140(8):627-38
15096334
Stroke. 2002 Apr;33(4):1152-62
11935076
N Engl J Med. 2008 May 1;358(18):1887-98
18378519
Nat Med. 2002 Nov;8(11):1263-9
12379850
Neurology. 1981 Dec;31(12):1552-4
7198209
Am J Geriatr Pharmacother. 2005 Mar;3(1):39-49
16089246
Lancet Neurol. 2008 Jun;7(6):483-93
18450517
Lancet. 2008 Jul 19;372(9634):207-15
18640457
Science. 1996 Oct 4;274(5284):99-102
8810256
Ann Neurol. 1996 Aug;40(2):149-56
8773595
Ann Intern Med. 2008 Mar 4;148(5):379-97
18316756
Am J Geriatr Pharmacother. 2006;4 Suppl A:S9-S24; quiz S25-S28
17157793
Clin Interv Aging. 2008;3(2):211-25
18686744
Can J Neurol Sci. 2008 Sep;35(4):508-9
18973072
CMAJ. 2003 Sep 16;169(6):557-64
12975222
Neurology. 2007 Jul 24;69(4 Suppl 1):S23-8
17646620
Neurobiol Aging. 1981 Fall;2(3):205-8
7312098
Lancet Neurol. 2004 Mar;3(3):184-90
14980533
J Neurol Neurosurg Psychiatry. 2005 Mar;76(3):315-9
15716518
Arch Intern Med. 2003 May 12;163(9):1069-75
12742805
Science. 2007 May 4;316(5825):750-4
17478722
Ann Neurol. 1999 Dec;46(6):860-6
10589538
Lancet Neurol. 2004 Oct;3(10):622-6
15380159
Neurodegener Dis. 2008;5(3-4):126-32
18322369
Brain. 2006 Nov;129(Pt 11):2840-55
17018549
J Neurol Neurosurg Psychiatry. 2009 Jun;80(6):600-7
19204022
Lancet. 2005 Dec 17;366(9503):2112-7
16360788
CMAJ. 2008 Jan 29;178(3):316-21
18227452
N Engl J Med. 2009 May 28;360(22):2302-9
19474427
Proc Natl Acad Sci U S A. 2005 May 10;102(19):6990-5
15867159
Am J Geriatr Psychiatry. 2006 Jul;14(7):561-72
16816009
Neurobiol Dis. 1997;4(5):313-28
9440120
Arch Neurol. 2004 Mar;61(3):378-84
15023815
Am J Occup Ther. 1999 Sep-Oct;53(5):471-81
10500855
Ann Intern Med. 2008 Mar 4;148(5):370-8
18316755
FASEB J. 1995 Dec;9(15):1570-6
8529836
Lancet. 2008 Jul 19;372(9634):216-23
18640458
Neurology. 1999 Apr 12;52(6):1158-65
10214737
Neurology. 2006 Feb 28;66(4):602-4
16505324
Lancet. 2001 Jan 20;357(9251):169-75
11213093